Pay in 4 interest-free payments of $7.22 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
In the SURPASS-2 diabetes trial, an open-label 40-week study randomised 1,879 patients with type 2 diabetes to tirzepatide 5, 10, or 15 mg or to semaglutide 1 mg
$ 349.99 USD $ 349.99 USD RX ONLY Inquire for Pricing $ 349.99 USD Injection GLP-1/GIP + Glycine supports appetite awareness, recovery, metabolic balance, and overall wellness support
Complementary repair Pairs angiogenesis (BPC-157) with cell migration (TB-500)
Body Protecting Compound-157 , , -
US$ 20.25
US$ 26.22
US$ 23.72
